BTL Vanquish Receives FDA Approval

The U.S. Food and Drug Administration (FDA) has approved the BTL Vanquish for circumferential reduction of the abdomenal area. The platform features a panel array that emits selective RF energy with the largest spot size in the industry to treat the entire core in one application (without touching patients’ skin). It creates a high-frequency energy field that targets the thermal effects into the fat layer while protecting surrounding skin tissue. “FDA clearance of BTL Vanquish marks a defining moment in our journey to provide physicians and their patients an elegant treatment option to target fat cells and bring about a reduction in the waist circumference,” says Andrea Morrison, BTL director of clinical development. “BTL is proud to offer patients a comfortable, affordable and noninvasive body shaping experience. This regulatory milestone underscores BTL’s commitment to deliver meaningful solutions to aesthetic patient care.”

Suggested Articles

The scholarship, hosted by Beauty Changes Lives, is for licensed business owners of salons and spas who seek to make the industry more sustainable.

Many businesses are thinking out the box when it comes to serving their clients, and that's true for some in the medical aesthetics field.

American Spa has curated list of some of our favorite spa, beauty, and wellness industry sites that are providing factual and actionable information.